Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells

被引：5

作者：

Nitin Mahajan

Veena Dhawan

机构：

[1] Postgraduate Institute of Medical Education & Research (PGIMER),Department of Experimental Medicine & Biotechnology, Research Block ‘B’

来源：

Molecular and Cellular Biochemistry | 2010年 / 338卷

关键词：

C-reactive protein; MMPs; TIMP-1; MAPK; Atorvastatin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The role of CRP as a mediator in atherosclerosis and inflammation is being investigated worldwide. In the present study, the effect of CRP on matrix metalloproteinases (MMP)-1, 2, 9, and their tissue inhibitor (TIMP-1) gene expression in THP-1 monocytic cell line was investigated. Specific mitogen activated protein (MAP) kinase (ERK, p38, and JNK) inhibitors were used to elucidate the signaling pathways involved. Effect of atorvastatin was determined in the presence of CRP on the expression of genes. Time and dose-dependent experiments were performed in the presence of CRP. The results showed that the treatment of THP-1 cells with 100 μg of CRP/ml/106 cells for 24 h enhanced the expression of MMPs and TIMP-1 genes significantly. CRP upregulated the expression of these genes via FcγRII and utilized ERK signaling pathway to transduce signals. Atorvastatin was able to significantly attenuate CRP-induced MMPs expression and augmented TIMP-1 gene expression significantly. In conclusion, CRP is not only a risk marker for vascular events, but also directly involved in the mechanisms leading to remodeling and destabilization of atherosclerotic plaque. Also, atorvastatin serves as potential therapeutic modality to curb these harmful events.

引用

页码：77 / 86

页数：9

共 210 条

[1] Paffen E(2006)C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 71 30-39
[2] de Maat MPK(2008)Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin Chem 54 24-38
[3] Packard RS(2002)Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 1557-1565
[4] Libby P(1993)C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor Blood 82 513-520
[5] Ridker PM(2004)C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization Arterioscler Thromb Vasc Biol 24 61-66
[6] Rifai N(2006)C-reactive protein-induced up-regulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin Life Sci 78 1021-1028
[7] Rose L(2008)C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque Atherosclerosis 196 129-135
[8] Buring JE(2004)Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators Circulation 101 235-238
[9] Cook NR(2002)Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 1439-1441
[10] Cermak J(2002)Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 1890-1896

← 1 2 3 4 5 6 7 8 9 10 →